BioSpace News Archive

Deals

CASI PHARMACEUTICALS, RECEIVES NASDAQ DEFICIENCY NOTICE

CASI Pharmaceuticals, Inc. today announced that on December 30, 2021 , CASI received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market.

January 3, 2022
·
4 min read
Genetown

Leap Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference

Leap Therapeutics, Inc. today announced that Douglas E. Onsi , President and Chief Executive Officer, will present a corporate overview at the 40th Annual J.P. Morgan Healthcare Conference.

January 3, 2022
·
3 min read
Genetown

Concert Pharmaceuticals to Present at H.C. Wainwright BIOCONNECT Virtual Conference

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will participate at the H.C. Wainwright BIOCONNECT Virtual Conference taking place January 10-13, 2022.

January 3, 2022
·
1 min read
Pharm Country

NRx Pharmaceuticals Files Provisional Patent for Stable Compositions of Aviptadil Suitable for Human Use

NRx Pharmaceuticals (Nasdaq: NRXP) announced today that it has filed a provisional composition of matter patent application with the US Patent and Trademark Office entitled “Stable, Buffer-free Compositions of Vasoactive Intestinal Peptide (VIP).”

January 3, 2022
·
6 min read
Deals

CinCor Pharma Launches Roadshow for Proposed Initial Public Offering of Common Stock

CinCor Pharma, Inc. today announced that it has launched an initial public offering of 11,000,000 shares of its common stock pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission.

January 3, 2022
·
3 min read
Business

PolyPid Announces Planned CEO Transition Current EVP & CFO, Dikla Czaczkes Akselbrad, Appointed CEO, Effective July 2022

PolyPid Ltd. today announced that its Board of Directors has appointed Dikla Czaczkes Akselbrad, currently the Company’s Executive Vice President and Chief Financial Officer, as PolyPid’s Chief Executive Officer, effective July 1, 2022.

January 3, 2022
·
6 min read
Genetown

QurAlis to Present at H.C. Wainwright BioConnect 2022 Virtual Conference

QurAlis Corporation today announced that its CEO and co-founder, Kasper Roet , PhD, will present an update about the company at the H.C. Wainwright BioConnect Virtual Conference held January 10-13, 2022.

January 3, 2022
·
1 min read
Medical Transcription Market Size, Share, Growth, Industry Analysis By Type, By Application, And Forecast to 2028

The industry analysis report is considered a valuable source of information about the global Medical Transcription industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

January 3, 2022
·
6 min read
Optic Neuritis Market Size, Share, Growth and Industry Analysis By Therapy, By Distribution Channel, and By Regional Forecast to 2028

The report focuses on current and emerging trends in the healthcare industry such as incorporation of IoT and ML to enhance efficiency of medical products.

January 3, 2022
·
7 min read
Transdermal Skin Patch Market Size, Share, Industry Analysis By Product Type, By Application, and By Region Forecast to 2028

The industry analysis report is considered a valuable source of information about the global Transdermal Skin Patch industry and lays stress on the future market scope, emerging industry trends, industry statistics, and market growth potential during the forecast years.

January 3, 2022
·
7 min read